An Update on Biosimilars in Rheumatic and Musculoskeletal Disorders.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 46, doi. 10.17925/RMD.2023.2.1.46
- By:
- Publication type:
- Article
Works matching IS 26351420 AND DT 2023 AND VI 2 AND IP 1
Results: 10
1
2
Health Equity in Rheumatology: A Global Health Perspective.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 42, doi. 10.17925/RMD.2023.2.1.42
- By:
- Publication type:
- Article
3
The Effect of Air Pollution on Rheumatic Diseases: A Review.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 37, doi. 10.17925/RMD.2023.2.1.37
- By:
- Publication type:
- Article
4
Challenges in Family Planning and Pregnancy for Women with Rheumatic Diseases.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 28, doi. 10.17925/RMD.2023.2.1.28
- By:
- Publication type:
- Article
5
Interleukin 6 Inhibition in Rheumatoid Arthritis: Highlight on Olokizumab.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 17, doi. 10.17925/RMD.2023.2.1.17
- By:
- Publication type:
- Article
6
Bimekizumab, a Humanized Monoclonal Immunoglobulin G1 Antibody for the Treatment of Psoriatic Arthritis: A Systematic Review.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 11, doi. 10.17925/rmd.2023.2.1.11
- By:
- Publication type:
- Article
7
Managing Inflammatory Bowel Disease in Spondyloarthritis.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 7, doi. 10.17925/RMD.2023.2.1.7
- By:
- Publication type:
- Article
8
The Adaption and Validation Processes in Remission Criteria for Rheumatoid Arthritis.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 4, doi. 10.17925/RMD.2023.2.1.4
- By:
- Publication type:
- Article
9
Strategies to Improve Adherence in Patients with Rheumatoid Arthritis.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 2, doi. 10.17925/RMD.2023.2.1.2
- By:
- Publication type:
- Article
10
Foreword.
- Published in:
- touchREVIEWS in RMD, 2023, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article